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Phosphatidylinositol 4-kinase IIβ negatively 
regulates invadopodia formation and suppresses 
an invasive cellular phenotype
ABSTRACT The type II phosphatidylinositol 4-kinase (PI4KII) enzymes synthesize the lipid 
phosphatidylinositol 4-phosphate (PI(4)P), which has been detected at the Golgi complex and 
endosomal compartments and recruits clathrin adaptors. Despite common mechanistic simi-
larities between the isoforms, the extent of their redundancy is unclear. We found that 
depletion of PI4KIIα and PI4KIIβ using small interfering RNA led to actin remodeling. Deple-
tion of PI4KIIβ also induced the formation of invadopodia containing membrane type I matrix 
metalloproteinase (MT1-MMP). Depletion of PI4KII isoforms also differentially affected trans-
Golgi network (TGN) pools of PI(4)P and post-TGN traffic. PI4KIIβ depletion caused increased 
MT1-MMP trafficking to invasive structures at the plasma membrane and was accompanied 
by reduced colocalization of MT1-MMP with membranes containing the endosomal markers 
Rab5 and Rab7 but increased localization with the exocytic Rab8. Depletion of PI4KIIβ was 
sufficient to confer an aggressive invasive phenotype on minimally invasive HeLa and MCF-7 
cell lines. Mining oncogenomic databases revealed that loss of the PI4K2B allele and under-
expression of PI4KIIβ mRNA are associated with human cancers. This finding supports the cell 
data and suggests that PI4KIIβ may be a clinically significant suppressor of invasion. We pro-
pose that PI4KIIβ synthesizes a pool of PI(4)P that maintains MT1-MMP traffic in the degrada-
tive pathway and suppresses the formation of invadopodia.
INTRODUCTION
The two human type II phosphatidylinositol 4-kinase (PI4KII) en-
zymes display 68% sequence identity across their conserved 
catalytic domains and exist in multiple subcellular membrane com-
partments (Balla and Balla, 2006; Minogue and Waugh, 2012). Since 
the molecular characterization of the PI4KIIs, a general model of 
PI4KII function in post–trans-Golgi network (TGN) traffic has gradu-
ally emerged in which the kinases generate phosphatidylinositol 
4-phosphate (PI(4)P), which is required for the recruitment of clathrin 
adaptors needed in TGN-to-endosomal traffic. PI4KIIs have been 
most extensively described in endosomes (Balla et al., 2002), the 
TGN (Wang et al., 2003), and at the plasma membrane (Minogue 
et al., 2006), as has PI(4)P (Hammond et al., 2014). The PI4KIIα iso-
form generates PI(4)P, which interacts with AP-1 (Wang et al., 2003), 
GGAs (Wang et al., 2007), and AP-3 (Salazar et al., 2005; Craige 
et al., 2008; Mossinger et al., 2012) and therefore has roles in TGN-
to-endosome and TGN-to–late endosomal trafficking known to be 
important in transport to the lysosome. More recently, a mechanism 
has been described involving the redirection of PI from phosphati-
dylinositol 3-phosphate (PI(3)P) into PI(4)P synthesis, which is 
required for exocytic traffic from endosomes. This pathway requires 
PI4KIIα and is significant because it represents an important step in 
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phosphotyrosine-rich protrusions termed invadopodia, which are 
capable of degrading extracellular matrix through the directed 
membrane traffic of MMPs (Poincloux et al., 2009). The overexpres-
sion of components of invadopodia such as cortactin in breast and 
squamous carcinomas and ovarian, bladder, and lung cancers is as-
sociated with a more aggressive phenotype and poorer patient 
prognosis (Paz et al., 2014). MT1-MMP is a key component of ma-
ture invadopodia and has been implicated in breaching of base-
ment membranes and invasion through interstitial collagen (Sabeh 
et al., 2004; Hotary et al., 2006). Trafficking to the plasma mem-
brane from endosomal compartments is a recognized pathway for 
the delivery of MT1-MMP to invadopodia (Steffen et al., 2008; Yu 
et al., 2012). However, the molecular machinery controlling the 
complex trafficking of this key protease is not fully understood.
The PI4KII enzymes have been associated with both the devel-
opment of breast cancer (Li et al., 2014) and metastasis of hepato-
cellular carcinoma (HCC; Mazzocca et al., 
2008), but links between the PI4KIIs and 
cellular processes such as actin reorganiza-
tion during oncogenesis are unclear. We 
therefore investigated the role of PI4KIIα 
and PI4KIIβ in actin remodeling and found 
that depletion of the enzymes had starkly 
different effects on the actin cytoskeleton. 
We also found that PI4KIIβ depletion spe-
cifically induced the formation of invado-
podia and was sufficient to convert HeLa 
and MCF-7 cells into an invasive pheno-
type. Loss of PI4KIIα and PI4KIIβ affected 
different PI(4)P TGN pools and post-TGN 
traffic. The steady-state distribution of 
MT1-MMP was also shifted from an endo-
somal to an exocytic trafficking route. 
Finally, database analyses indicated that 
PI4KIIβ was lost in human cancers, indicat-
ing that PI4KIIβ may be a clinically signifi-
cant tumor suppressor.
RESULTS
Depletion of PI4KII isoforms 
differentially affects the actin 
cytoskeleton
We used small interfering RNA (siRNA) to 
induce loss of PI4KII function. Gene silenc-
ing was confirmed by immunoblotting 72 h 
after transfection of HeLa cells with iso-
form-specific siRNA SMARTpools. We re-
peatedly achieved at least 85% reduction 
in levels of PI4KIIα and PI4KIIβ compared 
with nontargeted controls (Figure 1, A and 
B, and Supplemental Figure S1, A and B). 
When we specifically depleted PI4KII iso-
forms in this way, we noted that monolay-
ers of cells treated with PI4KIIβ siRNA were 
more dispersed than with PI4KIIα and con-
trols (unpublished results), as described 
previously (Mazzocca et al., 2008). To inves-
tigate this further, we stained the actin 
cytoskeleton with fluorescently labeled 
phalloidin and found that, in comparison to 
controls, loss of PI4KIIα led to increased 
actin stress fiber formation at leading 
the recycling of plasma membrane cargoes such as β1-integrin and 
the transferrin receptor (Ketel et al., 2016). PI4KIIα has also been 
implicated in human cancer (Li et al., 2010, 2014). PI4KIIβ functions 
in TGN-to-endosomal traffic by directly interacting with AP-1, play-
ing a role in developmental signaling by controlling the endosomal 
traffic of Frizzled, a receptor for Wnt (Wieffer et al., 2013). The PI4KII 
isoforms therefore produce lipids needed for different steps in post-
TGN trafficking.
Protease-dependent matrix remodeling performs key physio-
logical functions during embryo development and in the pathogen-
esis of metastatic disease. In metastatic cells, proteolytic degradation 
of extracellular matrix (ECM) is mediated by extracellular proteases 
such as the membrane type I metalloproteinase (MT1-MMP), whose 
increased expression is associated with a poor prognosis in a wide 
variety of human tumors (Egeblad and Werb, 2002). ECM invasion 
by tumor-derived cells is mediated in part by specialized actin- and 
FIGURE 1: PI4KIIα and PI4KIIβ exert different effects on the actin cytoskeleton. (A, B) Total cell 
lysates of PI4KIIα, PI4KIIβ, and control siRNA-transfected HeLa cells were analyzed for protein 
expression by Western blotting; α-tubulin served as a control for protein levels. (C) HeLa cells 
transfected with the siRNA SMARTpool as indicated for 36 h were reseeded onto collagen 
matrix and then costained for tyrosine phosphorylated proteins (red) and the actin cytoskeleton 
(green). Confocal sections were acquired at 0.25-μm intervals and rendered into orthogonal 
views. Single XY-sections of the basal surface. Single pY and F-actin channels are shown below. 
Scale bars, 10 μm. (D) Ratio of cortical actin to stress fiber intensity from three independent 
experiments (n = 20 cells). (E) Cells were also transfected with single siRNA oligos and rescued 
by reexpression of siRNA-resistant PI4KIIα and PI4KIIβ. Data are presented as mean ± SEM, 
*p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant.
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Loss of PI4KIIβ induces the formation of invadopodia
We sought to confirm the identity of the scattered actin-rich punc-
tae in Figure 1C formed as a result of loss of PI4KIIβ. Initially, we 
costained F-actin along with the early endosomal marker EEA1; 
however, these showed minimal colocalization (Supplemental 
Figure S2A), indicating that these punctae were distinct from actin 
comets localized to endosomal membranes (Taunton et al., 2000). 
Furthermore, these structures typically had average diameters of 
≤0.25 μm, mostly clustered in regions under the nucleus, and were 
thus suggestive of invadopodia (Garcia et al., 2014). To confirm the 
identity of these punctae, we immunostained cells for actin and cor-
tactin, the coincidence of which is diagnostic of invadopodia and 
related structures (Garcia et al., 2014).
We found that loss of PI4KIIβ, but not of PI4KIIα, induced the for-
mation of punctae staining positive for both markers in HeLa cells 
(Figure 2A). When we acquired confocal z-series data from PI4KIIβ-
depleted cells, we observed the colocaliza-
tion of actin and cortactin at the ventral sur-
face of gelatin-coated coverslips (Figure 2B), 
thereby confirming that these structures 
were indeed invadopodia. As further confir-
mation, we performed a positive control by 
treating cells with the phorbol ester phorbol-
12-myristate-13-acetate (PMA; Tatin et al., 
2006) and found that the actin- and cortactin-
rich structures were indistinguishable from 
those obtained by depletion of PI4KIIβ 
(Figure 2B). Key constituents of invadopodia 
are the matrix metalloproteinase MT1-MMP 
(Poincloux et al., 2009) and β1-integrin 
(Destaing et al., 2010). To determine whether 
the ventral structures contained known com-
ponents of mature invadopodia, we stained 
siRNA-treated cells plated on coverslips 
coated with a three-dimensional (3D) layer of 
collagen for MT1-MMP and β1-integrin or 
cortactin. Confocal microscopy demon-
strated the colocalization of these markers 
with MT1-MMP (Figure 2, C and D), particu-
larly on the ventral surface of PI4KIIβ-
depleted cells (Figure 2, E and F). Further-
more, these structures were seen to penetrate 
the 3D ECM when we performed Z-series 
confocal microscopy (Figure 2, E and F).
Loss of PI4KIIβ causes increased matrix 
degradation and migration through 
collagen gel
MT1-MMP requires posttranslational process-
ing to become active (Williams and Coppo-
lino, 2011). We therefore determined whether 
the structures formed upon the loss of PI4KIIβ 
expression were capable of ECM degrada-
tion. We plated target and control siRNA-
transfected HeLa cells on an ECM composed 
of cross-linked fluorescein isothiocyanate 
(FITC)–conjugated gelatin. In comparison 
with PI4KIIα and control siRNA–transfected 
cells, loss of PI4KIIβ resulted in an approxi-
mately fourfold increase in fluorescent matrix 
degradation in comparison with PI4KIIα 
(Figure 3, A and B). Areas of degradation also 
edges (Figure 1C). Cells also showed some clear focal colocaliza-
tion with phosphotyrosine (Figure 1C). Loss of PI4KIIβ, on the 
other hand, resulted in complete loss of actin stress fibers and in-
creased the intensity of cortical actin staining (Figure 1C), as well 
as of the formation of scattered, actin-rich punctae staining posi-
tive for phosphotyrosine (Figure 1C), which were absent in PI4KIIα 
and control siRNAs. Actin remodeling was confirmed by analyzing 
the ratio of cortical actin:stress fiber signals (Figure 1D), and nor-
mal actin phenotypes were restored by reexpression of siRNA-
resistant PI4KIIβ (Figure 1E and Supplemental Figure S1, C–F). The 
same rescue experiment with overexpressed GFP-PI4KIIα led to 
increased levels of cortical actin (Figure 1E), a likely consequence 
of increasing PI(4)P levels (Henmi et al., 2016), which would be 
expected to alter the actin cytoskeleton. These data indicate that 
loss of PI4KIIα and PI4KIIβ has markedly different effects on the 
actin cytoskeleton.
FIGURE 2: Depletion of PI4KIIβ induces invadopodia formation. (A) Confocal images showing 
immunostaining of cortactin (green) and F-actin (red). (B) Confocal images showing comparisons 
between HeLa cells transfected with PI4KIIβ siRNA and cells treated with 50 nM PMA. 
(C–F) Confocal images showing cells grown on thick layers of collagen and coimmunostained for 
MT1-MMP (magenta), (C) cortactin (green), or (D) β1-integrin (green). (E, F) XZ rendering of 
20 confocal sections acquired at 0.25-μm intervals, showing localization of MT1-MMP to ventral 
structures containing cortactin (E) or β1-Integrin (F). Horizontal lines indicate the position of the 
ECM surface. Scale bars, 20 μm.
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through the recruitment of clathrin adaptors. 
To address the question of how PI4KIIβ 
knockdown leads to increased matrix degra-
dation, we asked whether the PI4KII isoforms 
synthesized separate pools of PI(4)P and 
whether loss of this PI(4)P affected post-TGN 
membrane traffic. We visualized the PI(4)P 
generated by each PI4KII isoform by inhibit-
ing PI4KIII activities with wortmannin in con-
trol and siRNA-treated cells. When we 
stained siRNA-treated cells with the PI(4)P 
reporter glutathione S-transferase (GST)–
FAPP-PH, we noted that the intensity of 
staining in the Golgi region was affected in 
both PI4KIIα- and PI4KIIβ-knockdown cells 
but included signal from PI(4)P synthesized 
by the Golgi enzyme PI4KIIIβ (Supplemental 
Figure S3A). We therefore treated the same 
cells with wortmannin to inhibit PI4KIIIβ and 
fixed and stained the cells with recombinant 
GST-P4C, which is an unbiased PI(4)P re-
porter (Luo et al., 2015). The residual GST-
P4C signal allowed us to report the PI(4)P 
derived from the activity of PI4KIIα (PI(4)
PPI4KIIα) and PI4KIIβ (PI(4)PPI4KIIβ; Figure 4, 
A–C, and Supplemental Figure S4D), which 
in both cases localized to membranes in the 
Golgi region and on cytoplasmic vesicles 
(Figure 4, A–C). Cells in which PI4KIIα was 
depleted showed residual PI(4)PPI4KIIβ stain-
ing that colocalized with TGN46 (Figure 4, A 
and D). In contrast, PI(4)PPI4KIIα predomi-
nantly colocalized with the TGN marker syn-
taxin 6 (Figure 4, B and D). Colocalization of 
PI(4)P with syntaxin 6 and TGN46 was re-
stored upon expression of plasmids contain-
ing silent mutations rendering them resistant 
to siRNA (Figure 4, E and F, and Supplemen-
tal Figure S3, E and F). This demonstrates 
that the wortmannin-insensitive PI(4)PPI4KIIα 
and PI(4)PPI4KIIβ pools generated by the 
PI4KIIs exist in distinct subdomains of TGN/
endosomal membranes and that knockdown 
of each isoform affects a metabolically sepa-
rate PI(4)P compartment.
PI(4)P at the TGN is known to control the 
recruitment of the clathrin adaptor AP-1 in 
TGN-to-endosomal traffic (Wang et al., 2003; Wieffer et al., 2013), 
and we therefore reasoned that loss of TGN PI(4)P would affect this 
trafficking route. We investigated how loss of TGN PI(4)P altered the 
steady-state distribution of the cation-independent mannose-
6-phosphate receptor (CI-M6PR), finding that PI4KIIα and PI4KIIβ 
led to a significant loss in colocalization between PI(4)P and this 
AP-1 cargo (Figure 4, C and D). This effect was particularly marked 
in PI4KIIβ cells, which also displayed a more compact staining pat-
tern in the Golgi region and an absence of vesicular M6PR 
(Figure 4C). We also stained cells transfected with GFP-M6PR for 
AP-1 and found that PI4KIIβ siRNA cells showed reduced colocaliza-
tion between them (Figure 4, G and H), indicating defective TGN-
to-endosomal traffic. We tested the consequences on endolysosomal 
traffic by performing an epidermal growth factor receptor (EGFR) 
degradation assay and found that depletion of both PI4KIIα and 
corresponded to clusters of actin-rich punctae (Figure 3A), demon-
strating that they were the source of the gelatinolytic activity.
We also performed Transwell invasion assays to measure the 
ability of PI4KII-depleted cells to invade a 3D collagen matrix in 
response to chemoattractant (serum). Invasion in the absence of se-
rum was relatively low but significantly higher in PI4KIIβ siRNA cells. 
The introduction of serum to the lower chamber increased the num-
ber of migrating cells, with PI4KIIβ cells invading at approximately 
three times control values and two times that recorded for PI4KIIα-
depleted cells (Figure 3, C and D, and Supplemental Figure S2B).
PI4KIIα and PI4KIIβ isoforms synthesize separate pools of 
TGN PI(4)P involved in TGN-to-endosome traffic
PI4KII isoforms are not known to directly influence the actin cytoskel-
eton; instead, they control trafficking from the TGN to endosomes 
FIGURE 3: PI4KIIβ knockdown promotes ECM degradation and cell migration. (A) HeLa cells 
were reseeded onto FITC-gelatin–coated coverslips at 58 h posttransfection and then labeled for 
F-actin (red). Areas of proteolytic degradation are marked with arrows. (B) Percentage areas of 
degradation per total cell area in a 4 × 104 μm2 field. Data are mean ± SEM (n = 30; experiment 
performed in triplicate). (C, D) HeLa cells were reseeded onto Transwell inserts coated with type 
I collagen gel (100 μl of 2 mg/ml) 58 h posttransfection and then placed in a chemoattractant 
(10% FCS) for 12 h. (C) Representative fields of cells that traversed the collagen-coated 
membrane of a Transwell chamber in response to chemoattractant. (D) Quantitation of invasion 
expressed as the ratio of cells that migrated toward chemoattractant relative to the total 
number of cells seeded onto the serum-free upper chamber. Data are presented as mean ± SEM, 
*p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant.
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PI4KIIβ significantly impaired ligand-induced 
degradation of the EGFR (Figure 4, I and J). 
Given that loss of either PI4KII isoform im-
pairs EGFR degradation, we coimmunos-
tained MT1-MMP with the lysosomal marker 
CD63 and found that both PI4KIIα and PI4KIIβ 
siRNA resulted in reduced colocalization 
(Supplemental Figure S4, A and B). Collec-
tively these results show that loss of either 
PI(4)P pool affects TGN-to-endosome traffic 
and ultimately the degradation of cargo des-
tined for lysosomes.
Loss of PI4KIIβ leads to increased 
exocytic trafficking of MT1-MMP
MT1-MMP is delivered to invadopodia from 
endosomal compartments (Steffen et al., 
2008; Wiesner et al., 2013). We therefore 
considered that altered intracellular traffic 
might play a role in the increased localiza-
tion of MT1-MMP to invadopodia. We ana-
lyzed cell surface MT1-MMP staining versus 
total cellular MT1-MMP using fluorescence-
activated cell sorting (FACS) and found 
that loss of either PI4KII isoform led to an 
increase in total cellular MT1-MMP levels 
compared with controls (Supplemental 
Figure S4C); however, loss of PI4KIIβ led 
to an approximately threefold increase in 
MT1-MMP at the cell surface compared with 
control and PI4KIIα siRNA-transfected cells 
(Figure 5A).
Increased surface MT1-MMP could result 
from a decreased rate of endocytosis or an 
increased rate of exocytic trafficking. We 
therefore analyzed changes to the complex 
trafficking itinerary of MT1-MMP by coimmu-
nostaining MT1-MMP and a selective panel 
of Rab GTPases known to control traffic of 
cargo in endosomal and Golgi membranes 
(Wiesner et al., 2013). On loss of PI4KIIα and 
PI4KIIβ, MT1-MMP displayed decreased co-
localization with early endosomal Rab5 and 
the late endosomal Rab7 (Figure 5, B and C). 
A significant increase in colocalization was 
observed with the post-Golgi Rab8, but 
meaningful differences were not detected in 
the colocalization of MT1-MMP with late en-
dosomal Rab9 or the recycling endosomal 
Rab11 (Figure 5, B and C). This analysis dem-
onstrates that MT1-MMP trafficking is redi-
rected from an early endosomal (EE)–late en-
dosomal (LE) route to the plasma membrane 
via a Rab8 exocytic route.
Loss of PI4KIIβ confers invasiveness 
on MCF-7 cells
We asked whether PI4KIIβ depletion was suf-
ficient to convert the minimally invasive 
MCF-7 epithelial cell line into an invasive mi-
gratory phenotype. To test this, we evaluated 
the ability of PI4KIIβ-depleted MCF-7 cells 
FIGURE 4: PI4KIIα and PI4KIIβ siRNA affects separate pools of PI(4)P at the TGN and perturbs 
TGN-endosomal traffic. (A–C) Recombinant GST-tagged protein containing the P4C domain 
from the Legionella pneumoniae SidC gene (GST-P4C) was used to indirectly stain membrane 
pools of PI(4)P after wortmannin treatment. Samples were costained with (A) TGN46 or 
(B) syntaxin 6 or (C) transfected with mCherry-tagged (CI-M6PR). (D) Pearson’s r calculated for 
colocalization between PI(4)P and different TGN markers (20 cells, three independent 
experiments). (E, F) Pearson’s r for colocalization between PI(4)P and (E) TGN46 or (F) syntaxin 
6 after siRNA-mediated silencing with or without subsequent transfection with siRNA-resistant 
constructs. (G) Confocal images showing immunostaining for GFP-tagged CI-M6PR and 
adaptor AP-1. Scale bars, 10 μm. (H) Pearson’s r for colocalized pixel intensities between the 
green (GFP) and magenta (AP-1) channels (20 cells, three independent experiments). (I) HeLa 
cells were transfected with the indicated siRNA oligos and then serum starved and stimulated 
with 100 ng/ml EGF for indicated times before analysis of EGFR levels by Western blotting. 
(J) Signal intensities were quantified by densitometry. Data are mean ± SEM (n = 3; three 
independent experiments). *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant.
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gain in 12.8%. Copy number was normal in 
39.44% (n = 109 samples; Figure 7B). In 
HCC, both PI4K2B alleles were deleted in 
0.52%, 23.68% displayed heterozygous 
deletion, 64.73% had normal copy num-
bers, and 10.52% showed gain of PI4K2B 
(n = 190; Figure 7C). Significant reductions 
in PI4KIIβ mRNA expression were de-
tected in invasive breast carcinoma (n = 59; 
Figure 7D). We also analyzed survival data 
in the small number of cases available 
(Ciriello et al., 2015) and found that loss of 
PI4KIIβ expression correlated with poor 
survival in patients diagnosed with carci-
noma of the breast (Figure 7E). Together 
these data support the hypothesis that loss 
of PI4KIIβ is a risk factor in cancers.
DISCUSSION
Here we identify a post-TGN trafficking pathway that negatively 
regulates endolysosomal traffic and the formation of invadopodia. 
Loss of the PI4KII isoforms had dramatically different and unex-
pected effects on the actin cytoskeleton. An additional and striking 
feature of PI4KIIβ-depleted cells was the appearance of mature and 
functional invadopodia on the ventral surface.
PI4KIIβ plays a role in the development of a migratory pheno-
type in HCC (Mazzocca et al., 2008), but there is limited evidence for 
the direct involvement of mammalian PI4KII isozymes in actin regu-
lation. In contrast, several studies have described PI4KII functions in 
post-TGN traffic through PI(4)P biosynthesis and direct binding to 
clathrin adaptors AP-1 and AP-3 (Wang et al., 2003, 2007; Salazar 
et al., 2005; Craige et al., 2008), both pathways that contribute to 
endolysosomal traffic. PI4KIIα controls LE traffic of the EGFR 
(Minogue et al., 2006), endolysosomal traffic mediated by AP-3 
(Craige et al., 2008), and that of lysosomal membrane proteins and 
hydrolases such as the enzyme β-glucocerebosidase (Jovic et al., 
2012). This explains the similar effects of PI4KIIα and PI4KIIβ deple-
tion on EGFR degradation and LE traffic (Figure 4, I and J). PI4KIIβ 
localizes to the TGN and recruits AP-1, 
where it controls the endosomal sorting of 
Frizzled by traffic to degradative compart-
ments (Wieffer et al., 2013). There is there-
fore a substantial amount of data from our 
study and in published work indicating that 
each PI4KII contributes to TGN-EE/LE traffic 
by acting at different points in a pathway 
leading to lysosomal degradation. The 
other principal way in which the PI4KII iso-
forms differ is in the regulation of their PI4KII 
activity. The reported low activity of PI4KIIβ 
(Balla et al., 2002) and the need to recruit 
this isoform to membranes (Jung et al., 
2011) illustrate the importance of regulating 
its activity and suggest that this isoform is 
subject to tight regulation.
Few studies have investigated the role 
of PI4KIIs in TGN PI(4)P synthesis. Our data 
demonstrate for the first time that the 
PI4KII enzymes synthesize separate TGN 
pools of PI(4)P that are defined by the 
markers syntaxin 6 and TGN46. This is con-
sistent with our previous description of a 
to degrade FITC-gelatin matrix and invade a collagen layer in the 
Transwell chamber assay. PI4KIIβ-depleted MCF-7 cells degraded 
FITC-gelatin to an extent comparable to the highly invasive MDA-
MDB-231 line (Figure 6, A and B). Furthermore, they displayed 
increased invasiveness and the ability to invade collagen ECM 
and cross the membrane toward a chemoattractant (Figure 6C). 
These findings indicate that PI4KIIβ suppresses cell invasion in 
vitro.
Loss of PI4KIIβ is associated with human cancers
A region of human chromosome 4 encompassing the gene for 
PI4KIIβ (PI4K2B) contains tumor suppressor genes associated with 
sporadic colorectal carcinoma (Zheng et al., 2008). We therefore 
interrogated oncogenomic and transcriptomic data in the CBio-
Portal and Oncomine databases and found an association be-
tween heterozygous loss of PI4K2B and lung (squamous cell and 
adenocarcinoma), esophageal, pancreatic, prostate, breast, liver, 
and various other epithelial cancers (Figure 7A and Supplemental 
Figure S5). In pancreatic tumors, homozygous loss of PI4K2B was 
detected in 2.75% of samples, heterozygous loss in 43.1%, and 
FIGURE 5: PI4KIIβ depletion alters trafficking of MT1-MMP. (A) Surface-labeled and total 
MT1-MMP were analyzed using flow cytometry, and the relative percentage of MT1-MMP 
present on the cell surface versus total cellular MT1-MMP was calculated. (B) Confocal 
immunofluorescence images showing MT1-MMP (magenta) and the indicated Rab GTPases 
(green). (C) Pearson’s r for colocalization of MT1-MMP and the indicated Rab GTPases. Data are 
presented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant.
FIGURE 6: PI4KIIβ depletion is sufficient to confer a migratory and invasive phenotype. 
(A) siRNA-treated MCF-7 and untreated MDA-MB-231 cells were reseeded onto FITC-gelatin–
coated coverslips (green) at 58 h posttransfection and then labeled for F-actin (red). 
(B) Percentage areas of proteolytic degradation per total cell in a 4 × 104 μm2 field. Data are 
mean ± SEM (n = 30; experiments done in triplicate). (C) HeLa cells were reseeded onto 
collagen-coated Transwell inserts at 58 h posttransfection and placed in a chemoattractant (10% 
FCS) for 12 h. Histogram shows index of cell migration through an artificial barrier in response 
to chemoattractant. Data are mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001; ns, not 
significant.
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The reduced colocalization of MT1-MMP 
with Rab7, which acts at the EE-LE bound-
ary, in both PI4KII-depleted cells demon-
strates that the proteinase is not sorted to 
the LE. This is consistent with the elevated 
levels of MT1-MMP observed in both PI4KII 
knockdowns (Supplemental Figure S4C), 
the impaired degradation of the EGFR 
(Figure 4, I and J), and the failure of MT1-
MMP to traffic to CD63-containing lyso-
somes (Supplemental Figure 4, A and B). 
The most dramatic change in colocalization 
was a PI4KIIβ-specific increase in association 
with Rab8 membranes. Rab8 operates in a 
post-Golgi exocytic pathway that deter-
mines directional traffic to protrusions of the 
plasma membrane (Hattula et al., 2006) and 
is known to mediate the trafficking of MT1-
MMP (Bravo-Cordero et al., 2007). A mech-
anistic investigation of Rab8 was outside 
the scope of our study, but it is interesting to 
note that this GTPase was recently shown to 
regulate the cortical actin cytoskeleton 
(Bravo-Cordero et al., 2016), suggesting 
that the mistrafficking of Rab8 may contrib-
ute to the actin phenotype.
We were unable to detect increased traf-
ficking of MT1-MMP-GFP to invasive struc-
tures in live cell experiments; however, our 
attempts were fraught with technical diffi-
culties arising from the substantial MT1-
MMP signal present in multiple subcellular 
compartments that obscured invadopodia 
dynamics. The trafficking of MT1-MMP is 
known to be complex, and surface levels 
are controlled by endocytosis and exocyto-
sis from several compartments (Poincloux 
et al., 2009). The increased localization of 
MT1-MMP to the plasma membrane, in-
creased association with invasive protru-
sions, loss of colocalization in Rab5- and 
Rab7-positive compartments, and increased 
colocalization with exocytic Rab8 mem-
branes indicate that loss of PI4KIIβ and the 
associated pool of TGN PI(4)P causes dis-
equilibrium between the endolysosomal 
and exocytic trafficking routes controlling 
plasma membrane levels of MT1-MMP. Our data support a model 
in which MT1-MMP traffic is directed away from the default endoly-
sosomal pathway and forced into an exocytic pathway. One possi-
ble consequence of reduced MT1-MMP traffic into the endolyso-
somal pathway is increased recycling. Although we did not directly 
address this possibility, it remains likely because we also detected 
increased invadopodial localization of β1-integrin, a molecule 
known to be recycled through a pathway involving Rab8 and cotraf-
ficked with MT1-MMP (Macpherson et al., 2014). Of interest, the 
recent finding that PI4KIIα directs exocytic traffic of β1-integrin from 
endosomes to the plasma membrane when endosomal PI(3)P is lost 
(Ketel et al., 2016) suggests that endosomal PI(4)PPI4KIIα may play 
a role in β1-integrin delivery. Further investigation is required to de-
termine whether loss of PI(4)PPI4KIIβ results in an increase in PI(4)PPI4KIIα 
and whether this is accompanied by increased β1-integrin recycling. 
TGN-endosomal compartment enriched in syntaxin 6 containing 
highly active PI4KIIα (Simonsen et al., 1999; Waugh et al., 2003). 
The structurally unrelated, wortmannin-sensitive PI4KIIIβ also con-
tributes to PI(4)P synthesis in the Golgi of MDCK cells (Weixel 
et al., 2005), indicating that the Golgi complex contains at least 
three metabolically separate PI(4)P pools.
Cells such as HeLa and MCF-7 normally display minimal invasive 
potential and typically have low levels of surface MT1-MMP, reflect-
ing the importance of controlling surface metalloproteinase activity 
(Poincloux et al., 2009). Loss of either PI4KII isoform led to increased 
levels of the metalloproteinase, consistent with a general impair-
ment of endolysosomal degradative traffic; however, only depletion 
of PI4KIIβ caused increased levels of surface MT1-MMP, indicating 
that intracellular traffic of MT1-MMP was affected in an isoform-
specific manner.
FIGURE 7: Database analysis shows that loss of PI4KIIβ expression is associated with cancers. 
(A) Cross-cancer copy number alteration (CNA) summary of 18 selected cancer studies (including 
lung, esophageal, breast, prostate, and pancreatic tumors) for heterozygous loss of the PI4K2B 
allele. Threshold: minimum 5% altered samples, cBioPortal analysis (Cerami et al., 2012; Gao 
et al., 2013). adeno, adenocarcinoma; NEPC, neuroendocrine prostate cancer; Squ, squamous 
cell carcinoma. Sources of the data are given in parentheses: TCGA, The Cancer Genome Atlas; 
BCRC, British Columbia Cancer Research Center; UTSW, University of Texas Southwestern; 
FHCRC, Fred Hutchinson Cancer Research Center; SU2C, Stand Up To Cancer/Prostate Cancer 
Foundation (PCF); MICH, University of Michigan. (B) PI4K2B putative copy number alterations 
for pancreatic cancers (deletion or amplification) was analyzed using cBioPortal. (C) Overall 
change in PI4K2B copy number (deletion or amplification) in HCC was analyzed using cBioPortal. 
(D) Analysis of PI4KIIβ mRNA expression (Oncomine) in recurrent breast carcinoma (Finak breast, 
reporter: A_23_P18598). (E) Overall Kaplan–Meier survival graph of breast carcinoma case 
analysis (cBioPortal) with PI4KIIβ expression alteration (Ciriello et al., 2015).
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Small interfering RNAs
We silenced PI4KIIα and PI4KIIβ using ON-TARGETplus SMART-
pools siRNA oligonucleotides (GE Healthcare Dharmacon). Each 
comprised a mix of four siRNA duplexes targeting specific sequences 
within the named genes. We also used an ON-TARGETplus nontar-
geting pool (D-001810-10-05) as control. Gene silencing was con-
firmed by Western blotting of whole-cell lysates. PI4KII-knockdown 
phenotypes were rescued using single siRNA duplexes and the ecto-
pic expression of siRNA resistant plasmids as described previously 
(Mossinger et al., 2012; Wieffer et al., 2013). Further details are given 
in the Supplemental Materials and Supplemental Table S2.
Western immunoblotting
Cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.6, 150 mM 
NaCl, 0.5% sodium deoxycholate, 1% Triton X-100, 10% glycerol, 
0.5 mM ethylene diamine tetraacetic acid [EDTA], 0.5 mM ethylene 
glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid [EGTA], 
10 mM sodium fluoride, 10 mM sodium pyrophosphate, 0.2 mM 
Na3VO4) and 1× cOmplete Protease Inhibitor (Roche, Mannheim, 
Germany). Protein content was determined using the Lowry method 
(Bio-Rad, Hertfordshire, UK), and lysates were solubilized in 2× 
Laemmli sample buffer, separated using SDS–PAGE, blotted, and 
probed with respective antibodies. Blots were imaged on a Fluo-
rChem M Multifluor imaging system (ProteinSimple, San Jose, CA) 
and analyzed by densitometry using its gel analysis function.
Immunofluorescence microscopy
Cells were grown on glass coverslips, fixed, and probed with anti-
bodies of interest as previously (Minogue et al., 2006). Unless other-
wise stated, images were acquired using the 63×/1.4 numerical 
aperture lens on a Zeiss LSM 510 confocal microscope. Randomly 
chosen representative fields were selected and 12-bit images ac-
quired using identical detector gain and offset settings. Images 
were quantitatively analyzed for fluorescence intensities, pixel cor-
relations, area measurements, and cell densities using ImageJ soft-
ware (National Institutes of Health, Bethesda, MD). Full details are 
available in the Supplemental Materials.
Fluorescent matrix degradation
The ability of cells to degrade the extracellular matrix was analyzed 
using fluorescent gelatin matrix–coated culture dishes prepared ac-
cording to Bowden et al. (1999). Targeted or control siRNA-trans-
fected cells were seeded onto FITC-gelatin–coated coverslips and 
cultured for 12–18 h. Matrix degradation was calculated as the total 
area of matrix degradation (black holes) per total cell area ex-
pressed as a percentage (full details are given in the Supplemental 
Materials).
MT1-MMP trafficking
We used an established method (Kean et al., 2009). Briefly, MCF-7 
cells were reseeded onto coverslips thinly coated with collagen 
(5 μg/cm2) at 36 h posttransfection and grown in complete DMEM 
for 20 h at 37°C. Cells were then serum starved for 4 h to facilitate 
internalization of MT1-MMP. For trafficking of endogenous MT1-
MMP, cells were pulsed with anti–MT1-MMP antibody (Abcam, 
Cambridge, UK) for 1 h at 4°C. Cells were subsequently fixed with 
3.7% formaldehyde, permeabilized, and immunostained.
For flow cytometry experiments, we induced internalization of 
MT1-MMP by serum starvation and stimulated surface expression as 
described. Cells were lifted using FACS buffer (5 mM EDTA in phos-
phate-buffered saline [PBS], pH 7.4) and subsequent steps carried 
out at 4°C. Cells were probed with rabbit anti–MT1-MMP (Abcam) 
Integrin traffic to the plasma membrane plays important roles 
in tissue organization and is known to be dependent on PI(3)P (Ribeiro 
et al., 2011). Cross-talk between this PI monophosphate and the 
PI(4)P produced by the PI4KIIs is an unanswered question.
The conversion of the minimally invasive HeLa and MCF-7 cell 
lines to an invasive phenotype and the fact that tumor suppressor 
genes map closely to the chromosomal location of the PI4K2B allele 
(Zheng et al., 2008) led us to perform database searches. These 
showed that loss of heterozygosity of the PI4K2B allele and PI4KIIβ 
underexpression were associated with numerous cancers of epithe-
lial origin. PI4KIIβ underexpression was also associated with poorer 
patient survival; however, the low statistical power of the studies led 
to a relatively low probability value (p = 0.262). Although we are cau-
tious in drawing conclusions, we are aware that this finding may be 
highly significant and therefore speculate that PI4KIIβ acts as a 
metastasis suppressor by maintaining PI(4)P-dependent post-TGN 
traffic into the endolysosomal pathway. The association of PI4KIIβ 
with relatively common human cancers (lung, breast, liver, pancreas, 
and others) warrants further investigation, particularly because of 
the possibility that this putative suppressor pathway could be res-
cued by inhibition of PI(4)P phosphatases acting at the TGN.
It is notable that a developmental role for PI4KIIβ in zebrafish has 
been described (Wieffer et al., 2013). The pathological process of 
tumor cell invasion has many similarities with important processes 
during embryogenesis along with neurite outgrowth and angiogen-
esis. It is therefore possible that PI4KIIβ activity is subject to regula-
tion controlling physiological invasion. This hypothesis points to a 
PI(4)P-regulated switch that determines the decision between lyso-
somal degradation of cargoes and their traffic to the plasma mem-
brane that may be fundamentally important in the intracellular traffic 
of key molecules such as integrins and matrix metalloproteinases 
that determine tissue remodeling during development.
MATERIALS AND METHODS
Cell lines, culture, and transfection
HeLa and MCF7 cell lines were cultured in DMEM (Life Technolo-
gies, Paisley, UK) supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich, Dorset, UK) and maintained at 37°C and 5% CO2. 
MDA-MB-231 cells were cultured in Leibowitz’s L-15 medium (Life 
Technologies) supplemented with 15% FBS and 2 mM l-glutamine 
(Life Technologies) and maintained at 37°C, 0.1% CO2. All media 
were supplemented with antibiotics (1000 U/ml penicillin and 
0.1 mg/ml streptomycin; Sigma-Aldrich). DharmaFECT (GE Health-
care Dharmacon, Lafayette, CO) and Lipofectamine (Life Technolo-
gies) were used to transfect siRNAs and plasmids, respectively.
Antibodies and reagents
All primary antibodies with corresponding dilutions are listed in 
Supplemental Table S1. Highly cross-adsorbed Alexa Fluor–conju-
gated secondary antibodies and Alexa Fluor–conjugated phalloidin 
(1:250 dilution) were purchased from Molecular Probes (Life Tech-
nologies). Hoechst 33342 trihydrochloride was also from Molecular 
Probes and was used at 1:5000 for nuclear staining. Human recom-
binant EGF was purchased from Sigma-Aldrich. Unless otherwise 
stated, other reagents were from Sigma Aldrich.
Plasmids
siRNA-resistant GFP-tagged PI4KIIα and hemagglutinin-tagged 
PI4KIIβ were generous gifts from Volker Haucke (Leibniz Institut für 
Molekulare Pharmakologie, Berlin, Germany). mCherry and GFP-
tagged CI-M6PR were kindly provided by Mihaela Anitei (Technische 
Universität, Dresden, Germany).
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for 1 h, washed three times with PBS, and then labeled with anti–
rabbit Alexa Fluor antibody. Cells were analyzed using a FACS LSRII 
cell sorter (BD Biosciences, Oxford, UK), and ∼10,000 cells were 
counted per sample. Postacquisition analysis was performed using 
Flowjo software, version V10 (FlowJo LLC, Ashland, OR).
Transwell migration assay
This was performed in 8-μm-pore, collagen-coated Transwell cham-
bers (Corning, Tewksbury, MA). Cells were transfected with target or 
control siRNA in six-well plates and, after 48 h, resuspended in se-
rum-free medium and seeded at 5 × 104 into the upper chamber of 
the Transwell. Cells were allowed to migrate toward 10% FBS plus 
DMEM for 12 h. Migratory cells at the lower chamber were fixed and 
stained with Alexa 488–conjugated phalloidin, imaged using similar 
optical settings (20× Objective, Zeiss LSM 510 confocal micro-
scope), and counted in five random fields using ImageJ. Histograms 
represent relative invasion of the Transwell chamber, calculated as 
the number of cells counted at the lower chamber relative to the 
total number of cells seeded onto the upper chamber (details are 
give in the Supplemental Materials).
Data analysis
Prism 5 (GraphPad, La Jolla, CA) was used for statistical analysis. 
Data are presented as mean ± SEM from at least three independent 
experiments. Statistical comparisons were performed using one-
way analysis of variance followed by Tukey’s posttest at a 95% con-
fidence interval.
Oncogenomic database analysis
The cBIO Cancer Genomics Portal (http://cbioportal.org/; Cerami 
et al., 2012; Gao et al., 2013) and Oncomine (Rhodes et al., 2004) 
are open access resources for cancer genomics data sets containing 
data from 69 cancer genomics studies with 17,177 samples (cBIO) 
and 715 data sets with 86,733 samples (Oncomine). Heterozygous 
loss of the PI4K2B allele was analyzed in all cancers, as were copy 
number alterations in pancreatic cancers and hepatocellular carci-
noma. In addition, correlations of PI4KIIβ mRNA expression, recur-
rence, metastatic events, or overall survival in breast cancer cases 
were investigated.
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Antibodies 
Mouse monoclonal anti-PI4KIIα has been described (Simons et al., 2009) and 
polyclonal anti-PI4KIIβ(HPA004099)was from Atlas Antibodies (Sigma-Aldrich, St. 
Louis, MO). Mouse monoclonal anti γ-adaptin(AP-1, A4200) was from Sigma-Aldrich. 
Rabbit monoclonal anti-GAPDH (14C10) and anti-EGFR (D38B1) were from Cell 
Signalling Technology (CST, New England BioLabs, Hertfordshire, UK) as were 
antibodies to cortactin (H222), EEA1 (C45B10), Glutathione-S-transferase (GST, 
(26H1)),phospho-Tyrosine (P-Tyr-100), Rab5 (C8B1), Rab7 (D95F2), Rab8 (D22D8), 
Rab9 (D52G8), Rab11 (D4F5), syntaxin6 (C34B2). Horseradish-peroxidase (HRP)-
linked secondary antibodies were also from Cell Signalling Technology. Antibodies to α-
tubulin and highly crossed-adsorbed Alexa Fluor® conjugated secondary antibodies 
were from Molecular probes (Life Technologies, Ltd, Paisley, UK). Antibodies to β1-
integrin (CD29 (Clone 18/CD29)), and CD63 were from BD. Anti-TGN46 antibody was 
purchased from AbDSerotec (BioRad Labs, Inc). Anti MT1-MMP antibodies (ab78738 
and ab3644) were from Abcam while anti-MT1-MMP14 (LEM2/15.8) was purchased 
from Merck (Merck Millipore). Antibody dilutions are givenin Table S1.  
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Table S1. Antibodies and their respective dilutions for different applications 
Antigen  Host 
Species 
Isotype  Dilutions 
      Immuno‐
fluorescence 
Western 
Blotting 
Flow 
cytometry 
Anti‐mouse IgG, Alexa 
Fluor® conjugates 
Goat  Polyclonal   1:500    1:500 
Anti‐rabbit IgG, Alexa 
Fluor® conjugates 
Goat  Polyclonal  1:500    1:500 
Anti‐sheep IgG, Alexa 
Fluor® conjugates 
Donkey  Polyclonal  1:500     
CD63  Mouse  Monoclonal  1:400     
Cortactin (H222)  Rabbit  Polyclonal  1:100  1:1000   
EEA1 (C45B10)  Rabbit  Monoclonal  1:100     
EGF Receptor(D38B1)  Rabbit  Monoclonal    1:1000   
GAPDH (14C10)  Rabbit  Monoclonal     1:1000   
GST (26H1)  Mouse  Monoclonal   1:800     
HRP‐Linked anti‐mouseIgG  Horse  Polyclonal     1:1500   
HRP‐Linked anti‐rabbit IgG  Goat  Polyclonal     1:1500   
MT1‐MMP ([LEM‐2/15.8)]  Mouse  Monoclonal  10 µg/ml     
MT1‐MMP ([LEM‐2/63.1)]  Mouse  Monoclonal   1 µg/ml     
MT1‐MMP (ab3644)  Rabbit  Polyclonal  1 µg/ml  1:500  1:50 
Phospho‐Tyrosine  Mouse  Monoclonal   1:1600  1:2000   
PI4KIIα  Mouse  Monoclonal   1:6  1:4   
PI4KIIβ  Rabbit  Polyclonal  1:32  1:250   
Rab11 (D4F5)  Rabbit  Monoclonal   1:100     
Rab5 (C8B1)  Rabbit  Monoclonal   1:200     
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Rab7 (D95F2)  Rabbit  Monoclonal  1:100     
Rab8 (D22D8)  Rabbit  Monoclonal  1:200     
Rab9 (D52G8)  Rabbit  Monoclonal  1:100     
Syntaxin6 (C34B2)  Rabbit  Monoclonal  1:100     
TGN46  Sheep  Polyclonal  1:250     
α‐Tubulin  Mouse  Monoclonal    1:2000   
β1‐Integrin (Clone 
18/CD29) 
Mouse  Monoclonal  1:100     
γ‐Adaptin (AP‐1)  Mouse  Monoclonal  1:200     
 
Supplemental Methods 
Gene Silencing 
ON-TARGETplusSMARTpoolTMsiRNA oligonucleotides targeting PI4K2A or PI4K2B 
comprised a mix of four siRNA duplexes targeting specific sequences within the named 
genes (Table S2) - were purchased from DharmaconTM(GE Healthcare). Cells were at 
approximately 30% confluency on the day of transfection. Transfection mix containing 
Oligos and DharmaFECT4 transfection reagent was prepared according to the 
manufacturer’s protocol, applied for 4-6 hours followed by replacement with complete 
medium. Unless otherwise stated, cells were cultured for 72 hours prior to analysis. For 
rescue experiments, the following siRNAs were used; PI4KIIα: 
GGAUCAUUGCUGUCUUCAAUU (Mössinger et al., 2012), PI4KIIβ: 
GGUUCAAGUGGAAGUUACUUU(Wieffer et al., 2013) (Dharmacon).siRNA silencing 
was repeated after 48 hours with or without the addition of siRNA resistant plasmids to 
the transfection mix using the Lipofectamine2000 protocol (Invitrogen). At 4 hours post 
transfection, medium was replaced with complete medium and cells were cultured for 
24 hours prior to analysis.  
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EGFR degradation assay 
At 54 hours post-transfection, siRNA treated cells were serum starved in 0.5% FBS (in 
DMEM) for 18 hours. This was followed by two rinses in PBS and treatment with10µg/ml 
cycloheximide for one hour to inhibit nascent synthesis of receptor. Following two rinses 
with PBS, cells were treated with 100ng/ml EGF ligand for indicated times (Figure 4I) 
and then lysed in RIPA buffer. Protein content was quantified using the DC protein 
assay reagent (Bio-Rad), lysates resolved by SDS-PAGE and analysed by western 
blotting.  
Table S2:ON-TARGETplusSMARTpool targeting 4 different sequences within the 
primary transcripts of target genes.  
Target gene  siRNA sequence (5'‐3')  Target Region in primary 
transcript 
PI4K2A  GGUUGGUGGUGCUGGAUUA  944‐962 
  CAACACUGAUCGAGGCAAU  972‐990 
  GAGACGAGCCCACUAGUGU  64‐82 
  GCAUCGGGCUACCACCAAA  806‐824 
PI4K2B  GGUAGUAAAUGUCAGAGUA  1575‐1593 
  GUUACAAGGAGGCUGAAUA  918‐936 
  UCUCAAGGUUCAAGUGGAA  512‐530 
  UGGUUUGGCUUGUCAGUGA  759‐777 
 
Membrane lipid staining 
HeLa cells on 13mm glass coverslips were treated with 10µM wortmannin for 30 
minutes (Balla et al., 1997) followed by two rinses in PBS. Then we employed a 
previously described method (Hammond et al., 2009) to preserve Golgi membranes. In 
details, cells were fixed with 2% formalin(v/v in PBS) for 15 minutes at room 
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temperature. Following two rinses in PBS+50mM, cells were permeabilised by 
incubating with 20µM digitonin in buffer A (20mM PIPES (pH6.8), NH4Cl, 137 mMNaCl, 
2.7 mMKCl) for 5 minutes at room temperature. Coverslips were rinsed thrice with buffer 
A to remove digitonin and then cells were blocked with buffer A supplemented with 1% 
BSA and 50mM NH4Cl. 0.5 µg/ml GST-P4C (Echelon Biosciences, PI(4)P grip) was 
also included in the blocking buffer as a reporter for PI(4)P. Following incubation for 45 
minutes at room temperature, GST-tagged proteins were removed by three washes with 
buffer A. We then probed with antibodies as previously described. 
Preparation of gelatin coated dishes/culture plates 
To coat each well of a 6-well plate with gelatin(Sigma-Aldrich), 2ml 0.2% gelatin (w/v in 
PBS) was applied to each well and incubated for 10 minutes at 4oC on a rocking 
platform to allow solidification. Excess gelatin was aspirated and then 2ml 0.5% 
glutaraldehyde (v/v, in PBS) was pipetted into each well of a 6-well plate followed by 
incubation for 30 minutes at 4oC with gentle rocking. Each well was subsequently 
washed three times with PBS followed by equilibration with culture medium at 37oC for 
30 minutes.  
Preparation of fluorescent labelled coverslips 
We used a previously described method (Bowden et al., 2001). In details, approximately 
200µl FITC-conjugated gelatinwas pipetted onto clean 13 mm glass coverslips in 24-
well plates and then incubated on ice for 30 minutes. Excess FITC-gelatinwas gently 
aspirated and coated coverslips were treated with 0.5% glutaraldehyde (v/v in PBS) for 
15 minutes at 4oC. Coverslips were washed thrice (5 minute per wash) with PBS and 
then treated with 0.5% sodium borohydride (v/v in PBS) for 3 minutes at room 
temperature to quench glutaraldehyde auto-fluorescence. Coverslips were washed 
three timeswith PBS and then equilibrated with serum free medium for 30 minutes prior 
to cell seeding. 
Preparation of collagen coated coverslips 
To prepare thin layers of collagen matrices on glass coverslips, 50µg/mL of type I 
collagen(Gibco®) was prepared in 20mM acetic acid as described by the manufacturer 
  S6
and then added at 5µg/cm2 to each cover slip (100 µl required to coat a 13 mm 
coverslip). Coated coverslips were incubated at room temperature for one hour. Excess 
solution was carefully aspirated from each well followed by three rinses with sterile 1x 
PBS to remove the acid, prior to cell seeding.   
To prepare 3D-collagen (thick layer), type I collagen was neutralised on ice to 2 
mg/ml as described by the manufacturer. 13 mm glass coverslips in 24-well plates were 
coated with 0.1 ml neutralised collagen and allowed to polymerise for 30 minutes at 
37oC in humidified incubator. 
Image Analysis 
Quantitation of fluorescent intensities 
Fluorescent intensities were quantified (Hammond et al., 2009) with some modifications 
with the aid of the NIH ImageJ software. Images were converted to greyscale and 
thresholded using the same parameters across all fields. Regions of interest were then 
selected using the ROI command and integrated pixel intensities were measured at 
randomly selected fields. The integrated pixel intensity, I was normalized to pooled 
results across independent experiments. This was done using the following relation; 
 
Where Ictrlrepresents the mean intensity for the control siRNA transfected cells in this 
case and Ibgrepresents the intensity of the background specimen in which antibodies or 
lipid binding probes were omitted.  
Colocalisation analysis 
Multi-channel confocal image stacks were converted to 8-bit single images and pixel co-
localisation in two different channels was analysed using the Pearson’s correlation 
coefficient (r) with the aid of the JACoP plugin on ImageJ(Bolte and Cordelières, 2006).  
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Quantitative analysis of actin based structures 
This was done using ImageJ v1.50f with Java version 1.6.0_37 (64 bit) running under 
Linux (kernel version 3.2.0-97-generic). Multi-channel, 8-bit, fluorescent images were 
segmented using global intensity thresholds (Thr) for (red) and (green)such that 
ThrG=25 on the actin channel and ThrR=73 on the anti-pY channel. We then computed 
the total area of actin and anti-pY foreground pixels on each images using the Measure 
command of ImageJ. The ratio of the segmented anti-pY/actin area was calculated 
using LibreOfficeCalc (version 5.0.4.2). 
Relative invasion 
Relative invasion of the Transwell migration chamber was calculated by dividing the 
number of cells that migrated to the lower chamber in response to chemoattractantby 
the number of cells seeded (5?104) onto the serum-free upper chamber.  
 
Analysis of matrix degradation 
Confocal images of F-actin and degraded matrix were captured using a Nikon confocal 
microscope equipped with NIS-nd2 software. Experiments were carried out in triplicates 
with at least 20 cells captured per experiment. The ImageJ software was used to 
compute the area of degradation in a 4x104µm2 field and the number of cells for each 
field. The total degraded area was expressed as a percentage of the total cell area.  
Supplemental Figure Legends 
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Figure S1. (A)Total cell lysates of PI4KIIα, PI4KIIβ, GAPDH and control siRNA-
transfected HeLa cells were analysed by western blot using antibodies specific for the 
specified proteins. (B)HeLa cells were analysed for protein expression by western 
blotting; α-tubulin served as a control for protein levels. (C)Rescue of siRNA in HeLa 
cells. Western blots show loss and re- expression of siRNA-resistant recombinant 
PI4KIIα and PI4KIIβ following siRNA-mediated depletion. Asterisk indicates a proteolytic 
fragment resulting from the overexpression of GFP-PI4KIIα. (D) Confocal images 
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showing expression of siRNA resistant GFP-tagged PI4KIIα and HA-tagged PI4KIIβ, 
Scale Bars, 10 µM. (E and F)Confocal images showing immunostaining for phospho-
tyrosines (red) and F-actin (green) following siRNA mediated silencing with or without 
transfection with siRNA resistant constructs.Data are presented as mean ± SEM, *; 
p<0.05, **; p<0.01, ***; p<0.001; ns, not significant. 
 
Figure S2.(A)Confocal images showing that scattered actin punctae induced upon 
PI4KIIβ depletion do not contain the endosomal marker EEA1. (B)Migration of siRNA 
treated cells via collagen-coated Transwell inserts towards a chemoattractant. Transwell 
membranes were coated with 100 µl type 1 collagen (2 mg/ml) gel. After staining with 
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Alexa-488 labelled phalloidin, fixed cells were visualised by confocal microscopy. 
Optical sections were acquired at 2.5 µm apart and are shown side by side with 
increasing depth. 
 
Figure S3. (A)A recombinant GST-fusion of the PH domain of FAPP1 (GST-PH-
FAPP1) was used to indirectly stain membrane pools of PI(4)P. Samples were co-
immunostained with TGN46(B)Recombinant GST-tagged protein containing the P4C 
domain from the Legionella pneumoniaeSidC protein (GST-P4C) was used to indirectly 
stain membrane pools of PI(4)P in the absence of wortmannin. (C)The ability of 10 
µMwortmannin to inhibit PI 3-kinases was confirmed by probing fixed cells with GST-
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tagged FYVE domain of Hrs (GST-2X-FYVEHrs). Cells were co-immunostained with 
early endosome marker, EEA1.(D)Quantification of staining of membrane pools of 
PI(4)P identified by GST-P4C after treatment with 10µM wortmannin.(E and F) Confocal 
images showing immunostaining for GST-P4C (green) and syntaxin 6 or TGN46 
(magenta) following siRNA mediated silencing with or without rescue with siRNA-
resistant constructs.Data are presented as mean ± SEM, *; p<0.05, **; p<0.01, ***; 
p<0.001; ns, not significant. 
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Figure S4. (A)Immunofluorescent staining of MT1-MMP and the lysosomal marker, 
CD63. (B)Pearson’s correlation coefficients were calculated for co-localised pixels 
between MT1-MMP (green) and CD63 (magenta) channels. (C)Surface 
(unpermeablised cells) and total cellular (permeabilised with 0.05% Triton X-100) MT1-
MMP levels were analysed by flow cytometry. Data are presented as mean ± SEM, *; 
p<0.05, **; p<0.01, ***; p<0.001; ns, not significant. 
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Figure S5.Cross cancer histogram showing heterozygous loss of PI4K2B across all 
cancer types. CBio Database analysis. 
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